Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-β1 in vitro

International Journal of Molecular Medicine

Volumn 27, Issue 2, 2011, Pages 187-193

  Lv, Zhi Dong ^a   Na, Di ^a   Ma, Xiao Yang ^a   Zhao, Chong ^a   Zhao, Wei Jun ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Human peritoneal mesothelial cells; Peritoneal carcinomatosis; Peritoneal fibrosis; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 3; CYTOKERATIN; FIBRONECTIN; SMAD2 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MESOTHELIUM CELL; MYOFIBROBLAST; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BIOLOGICAL MARKERS; CADHERINS; CELLS, CULTURED; COLLAGEN; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MYOFIBROBLASTS; PERITONEAL CAVITY; PHOSPHORYLATION; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 78751666318     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.574     Document Type: Article

References (23)

1. Sugarbaker PH and Yonemura Y: Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58: 96-107, 2000.
2. Otsuji E, Kuriu Y, Okamoto K, Ochiai T, Ichikawa D, Hagiwara A and Yamagishi H: Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg 188: 327-332, 2004. (Pubitemid 39278295)
3. Ahmed N, Riley C, Rice G and Quinn M: Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis 22: 391-402, 2005. (Pubitemid 41609298)
4. Lessan K, Aguiar DJ, Oegema T, Siebenson L and Skubitz AP: CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154: 1525-1537, 1999. (Pubitemid 29226447)
5. Krzysztof KZ, Justyna MP and Katarzyna K: Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion. Am J Pathol 174: 1231-1240, 2009.
6. Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M: Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as 'soil' for peritoneal dissemination. Cancer 77: S1668-S1675, 1996.
7. Epperly MW, Guo H, Gretton JE and Greenberger JS: Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 29: 213-224, 2003. (Pubitemid 36936649)
8. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F and Lopez- Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-413, 2003. (Pubitemid 36159357)
9. Xu J, Lamouille S and Derynck R: TGF-β-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009.
10. Imamichi Y and Menke A: Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition. Cells Tissues Organs 185: 180-190, 2007. (Pubitemid 46956859)
11. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250, 2000.
12. Verrecchia F and Mauviel A: Transforming growth factor-beta and fibrosis. World J Gastroenterol 13: 3056-3062, 2007.
13. Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003. (Pubitemid 38063698)
14. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E and Koteish A: Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282: 22089-22101, 2007.
15. Liu Q, Mao H, Nie J, Chen W, Yang Q, Dong X and Yu X. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int 3: S88-S95, 2008.
16. Shi Y and Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003.
17. Dijke P and Hill CS: New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29: 265-273, 2004.
18. Shirai K, Saika S, Tanaka T, Okada Y, Flanders KC, Ooshima A and Ohnishi Y: A new model of anterior subcapsular cataract: involvement of TGFbeta/Smad signaling. Mol Vision 12: 681-691, 2006.
19. Schiller M, Javelaud D and Mauviel A: TGF-beta-induced SMAD signaling and gene regulation: consequences for extra-cellular matrix remodeling and wound healing. J Dermatol Sci 35: 83-92, 2004.
20. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E and Norcross MA: Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 186: 1865-1872, 1997.
21. Su XH, You ZY and Xu HM: Relationship between the pathology and TGF-β1 presented in gastric cancer and peritoneal lavage fluid. J China Med University 34: 164-166, 2005.
22. Verrecchia F and Mauviel A: Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118: 211-215, 2002.
23. Na D, Lv ZD, Liu FN, Xu Y, Jiang CG, Sun Z, Miao ZF, Li F and Xu HM: Transforming growth factor β1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis. Int J Mol Med 26: 325-332, 2010.